How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
12
PLSE Quote, Financials, Valuation and Earnings
Last price:
$13.61
Seasonality move
:
7.85%
Day range:
$13.55 - $14.55
52-week range:
$12.56 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10,392.65x
P/B ratio:
9.83x
Volume:
104.8K
Avg. volume:
178K
1-year change:
-29.9%
Market cap:
$911.6M
Revenue:
--
EPS (TTM):
-$1.14
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$250K | -- | -- | -- | $22.00 |
|
AORT
Artivion, Inc.
|
$116.4M | $0.18 | 19.64% | -75% | $51.71 |
|
IVF
INVO Fertility, Inc.
|
$1.9M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.7M | -- | -57.64% | -57.14% | $2.30 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
SINT
SINTX Technologies, Inc.
|
$300K | -$0.55 | -44.65% | -56.43% | $12.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$13.55 | $22.00 | $911.6M | -- | $0.00 | 0% | 10,392.65x |
|
AORT
Artivion, Inc.
|
$41.29 | $51.71 | $2B | -- | $0.00 | 0% | 4.35x |
|
IVF
INVO Fertility, Inc.
|
$1.62 | -- | $24.5M | -- | $0.00 | 0% | 0.03x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.91 | $2.30 | $45.7M | -- | $0.00 | 0% | 3.01x |
|
NTRB
Nutriband, Inc.
|
$4.70 | $15.00 | $57.1M | -- | $0.00 | 0% | 23.45x |
|
SINT
SINTX Technologies, Inc.
|
$3.32 | $12.25 | $12.8M | -- | $0.00 | 0% | 5.63x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
7.84% | 1.330 | 0.66% | 9.82x |
|
AORT
Artivion, Inc.
|
37.39% | 2.291 | 13.06% | 1.88x |
|
IVF
INVO Fertility, Inc.
|
41.99% | 0.410 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 3.209 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 3.036 | 0.32% | 7.07x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 0.781 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
-$449K | -$20.4M | -67.74% | -73.32% | -23682.56% | -$13.1M |
|
AORT
Artivion, Inc.
|
$70.9M | $11.6M | -1.36% | -2.63% | 10.26% | $15.9M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
Pulse Biosciences, Inc. vs. Competitors
-
Which has Higher Returns PLSE or AORT?
Artivion, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of 5.73%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Artivion, Inc.'s return on equity of -2.63%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M AORTArtivion, Inc.62.55% $0.13 $700.7M -
What do Analysts Say About PLSE or AORT?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 62.36%. On the other hand Artivion, Inc. has an analysts' consensus of $51.71 which suggests that it could grow by 25.25%. Given that Pulse Biosciences, Inc. has higher upside potential than Artivion, Inc., analysts believe Pulse Biosciences, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 AORTArtivion, Inc.4 1 0 -
Is PLSE or AORT More Risky?
Pulse Biosciences, Inc. has a beta of 1.687, which suggesting that the stock is 68.669% more volatile than S&P 500. In comparison Artivion, Inc. has a beta of 1.587, suggesting its more volatile than the S&P 500 by 58.733%.
-
Which is a Better Dividend Stock PLSE or AORT?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Artivion, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Artivion, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or AORT?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Artivion, Inc. quarterly revenues of $113.4M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Artivion, Inc.'s net income of $6.5M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Artivion, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,392.65x versus 4.35x for Artivion, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,392.65x -- $86K -$19.4M AORTArtivion, Inc.4.35x -- $113.4M $6.5M
-
Which has Higher Returns PLSE or IVF?
INVO Fertility, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -150.51%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About PLSE or IVF?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 62.36%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 8788.89%. Given that INVO Fertility, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe INVO Fertility, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 IVFINVO Fertility, Inc.0 0 0 -
Is PLSE or IVF More Risky?
Pulse Biosciences, Inc. has a beta of 1.687, which suggesting that the stock is 68.669% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.606, suggesting its more volatile than the S&P 500 by 160.551%.
-
Which is a Better Dividend Stock PLSE or IVF?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or IVF?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,392.65x versus 0.03x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,392.65x -- $86K -$19.4M IVFINVO Fertility, Inc.0.03x -- $1.8M -$2.6M
-
Which has Higher Returns PLSE or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -59.08%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About PLSE or NMTC?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 62.36%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 153.64%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Pulse Biosciences, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is PLSE or NMTC More Risky?
Pulse Biosciences, Inc. has a beta of 1.687, which suggesting that the stock is 68.669% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.
-
Which is a Better Dividend Stock PLSE or NMTC?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NMTC?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,392.65x versus 3.01x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,392.65x -- $86K -$19.4M NMTCNeuroOne Medical Technologies Corp.3.01x -- $2.7M -$1.6M
-
Which has Higher Returns PLSE or NTRB?
Nutriband, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -1118.87%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About PLSE or NTRB?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 62.36%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 219.15%. Given that Nutriband, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe Nutriband, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NTRBNutriband, Inc.1 0 0 -
Is PLSE or NTRB More Risky?
Pulse Biosciences, Inc. has a beta of 1.687, which suggesting that the stock is 68.669% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.840, suggesting its more volatile than the S&P 500 by 84.015%.
-
Which is a Better Dividend Stock PLSE or NTRB?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NTRB?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Nutriband, Inc. quarterly revenues of $346.1K. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,392.65x versus 23.45x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,392.65x -- $86K -$19.4M NTRBNutriband, Inc.23.45x -- $346.1K -$3.9M
-
Which has Higher Returns PLSE or SINT?
SINTX Technologies, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -1701.44%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About PLSE or SINT?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 62.36%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 268.98%. Given that SINTX Technologies, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 SINTSINTX Technologies, Inc.2 0 0 -
Is PLSE or SINT More Risky?
Pulse Biosciences, Inc. has a beta of 1.687, which suggesting that the stock is 68.669% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.649, suggesting its less volatile than the S&P 500 by 35.053%.
-
Which is a Better Dividend Stock PLSE or SINT?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or SINT?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than SINTX Technologies, Inc. quarterly revenues of $208K. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 10,392.65x versus 5.63x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.10,392.65x -- $86K -$19.4M SINTSINTX Technologies, Inc.5.63x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
72
BNAI alert for Jan 29
Brand Engagement Network, Inc. [BNAI] is down 16.89% over the past day.
Buy
82
STX alert for Jan 29
Seagate Technology Holdings Plc [STX] is up 0.83% over the past day.
Buy
84
GDXU alert for Jan 29
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 12.19% over the past day.
